Results 11 to 20 of about 908 (165)

Osteosarcopenic Obesity: Current Knowledge, Revised Identification Criteria and Treatment Principles. [PDF]

open access: yesNutrients, 2019
Osteosarcopenic obesity (OSO) syndrome describes the simultaneous deterioration of bone, muscle and excess fat, resulting in reduced functionality and systemic metabolic dysregulation. The key component contributing to this may be ectopic fat in the viscera, bone and muscle.
Kelly OJ   +3 more
europepmc   +6 more sources

Sex-Specific Associations between Serum Ferritin and Osteosarcopenic Obesity in Adults Aged over 50 Years. [PDF]

open access: yesNutrients, 2022
We investigated the sex-specific association between ferritin and adverse body composition in adults aged over 50 years in a population-based cohort. A total of 25,546 participants (16,912 women; 8634 men) were stratified into three groups by the tertiles of ferritin.
Chung SJ   +5 more
europepmc   +5 more sources

Association of serum vitamin D with osteosarcopenic obesity: Korea National Health and Nutrition Examination Survey 2008-2010. [PDF]

open access: yesJ Cachexia Sarcopenia Muscle, 2017
BACKGROUND: Serum vitamin D levels have been reported to be associated with individual components of body composition. However, the relationship between serum vitamin D and combined indices of adverse body composition is largely unknown.
Kim J, Lee Y, Kye S, Chung YS, Lee O.
europepmc   +5 more sources

Osteosarcopenic obesity: the role of bone, muscle, and fat on health. [PDF]

open access: yesJ Cachexia Sarcopenia Muscle, 2014
Osteopenia/osteoporosis, sarcopenia, and obesity are commonly observed in the process of aging, and recent evidence suggests a potential interconnection of these syndromes with common pathophysiology. The term osteosarcopenic obesity has been coined to describe the concurrent appearance of obesity in individuals with low bone and muscle mass.
Ormsbee MJ   +6 more
europepmc   +8 more sources

Osteosarcopenic obesity and its components—osteoporosis, sarcopenia, and obesity—are associated with blood cell count-derived inflammation indices in older Chinese people [PDF]

open access: yesBMC Geriatrics, 2022
Background The aim of this study was to investigate the associations of osteosarcopenic obesity (OSO) and its components with complete blood cell count-derived inflammation indices. Methods In this cross-sectional study, data of 648 participants aged ≥60 
Yi-zhen Nie   +5 more
doaj   +2 more sources

Bergamot (Citrus bergamia), a (Poly)Phenol-Rich Source for Improving Osteosarcopenic Obesity: A Systematic Review [PDF]

open access: yesFoods
This systematic review investigates the potential of bergamot, a polyphenol-rich citrus fruit, in improving osteosarcopenic obesity, a condition characterized by the simultaneous presence of osteoporosis, obesity, and sarcopenia.
Giuseppe Mazzola   +13 more
doaj   +2 more sources

Discovering the Individualized Factors Associated with Sarcopenia and Sarcopenic Obesity Phenotypes-A Machine Learning Approach. [PDF]

open access: yesNutrients, 2023
The literature shows how sarcopenia often occurs along with different phenotypes based either on the concomitant presence of adipose tissue excess (i.e., sarcopenic obesity, SO), or osteopenia/osteoporosis (osteosarcopenia, OS), or the combination of the
Moroni A   +6 more
europepmc   +6 more sources

Long-term effect of physical inactivity on osteosarcopenic obesity – a MRI-based investigation from a population-based cohort [PDF]

open access: yesBMC Musculoskeletal Disorders
Background The hazardous triad of osteopenia, sarcopenia and obesity was recently defined as osteosarcopenic obesity (OSO). The causes for OSO appear to be multifactorial, including age and gender, as well as chronic diseases.
Lena Sophie Kiefer   +9 more
doaj   +2 more sources

Osteosarcopenic obesity in cardiovascular patients. Controversial and open issues

open access: yesКардиоваскулярная терапия и профилактика, 2021
See “Inflammaging in the pathogenesis of chronic non-communicable diseases”, Kim O. T. in Opinion of invited editor, pp. 54-55.The study of osteosarcopenic obesity (OSO) in patients with cardiovascular diseases (CVDs) in recent years has caused a dis ...
K. E. Krivoshapova   +3 more
doaj   +3 more sources

Osteosarcopenic obesity and the progression of physical frailty, cognition function, and mental health: First longitudinal evidence from ELSA [PDF]

open access: yesThe Journal of Nutrition, Health and Aging
Background: Osteosarcopenic obesity (OSO), the coexistence of osteoporosis, sarcopenia, and obesity, has been linked to poor health outcomes, but its longitudinal impact on aging-related trajectories remains unclear.
Qihang Yang   +3 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy